Humana shares upgraded to Buy as stock rebounds and long-term growth targets set.

Humana shares jump 48% in a month on Medicare Advantage growth and strong Q1 results

Humana's stock has surged 48% over the past month, outperforming peers like UnitedHealth and Cigna, driven by strong Medicare Advantage (MA) growth and favorable regulatory decisions. The company reported Q1 2026 adjusted EPS of $10.31, beating estim...